These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 772720)

  • 1. Studies on the cholinergic and dopaminergic innervation of the neostriatum with the help of intraneostriatal injections of drugs.
    Fuxe K; Ungerstedt U
    Pharmacol Ther B; 1976; 2(1):29-36. PubMed ID: 772720
    [No Abstract]   [Full Text] [Related]  

  • 2. Transmitters for the afferent and efferent systems of the neostriatum and their possible interactions.
    Kim JS
    Adv Biochem Psychopharmacol; 1978; 19():217-33. PubMed ID: 29447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour.
    Fuxe K; Ungerstedt U
    Pharmacol Ther B; 1976; 2(1):41-7. PubMed ID: 817332
    [No Abstract]   [Full Text] [Related]  

  • 4. Lesions of the nigro-neostriatal dopamine neurons or the bulbo-spinal norepinephrine and 5-hydroxytryptamine neurons in rats: action of drugs.
    Andén NE
    Pharmacol Ther B; 1975; 1(3):371-80. PubMed ID: 772707
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.
    Wolfarth S
    Pol J Pharmacol Pharm; 1976; 28(5):469-93. PubMed ID: 796834
    [No Abstract]   [Full Text] [Related]  

  • 6. Is cholinergic activity of the caudate nucleus involved in memory?
    Prado-Alcalá RA
    Life Sci; 1985 Dec; 37(23):2135-42. PubMed ID: 3906332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of the dopamine mechanisms mediating stereotyped behaviour and hyperactivity in the nucleus accumbens and caudate-putamen.
    Costall B; Naylor RJ; Cannon JG; Lee T
    J Pharm Pharmacol; 1977 Jun; 29(6):337-42. PubMed ID: 18569
    [No Abstract]   [Full Text] [Related]  

  • 8. Retrograde amnesia and cholinergic systems in the caudate-putamen complex and dorsal hippocampus of the rat.
    Haycock JW; Deadwyler SA; Sideroff SI; McGaugh JL
    Exp Neurol; 1973 Oct; 41(1):201-13. PubMed ID: 4795498
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholinergic modification of abnormal involuntary movements induced in the guinea-pig by intrastriatal dopamine.
    Costall B; Naylor RJ
    J Pharm Pharmacol; 1975 Apr; 27(4):273-5. PubMed ID: 239121
    [No Abstract]   [Full Text] [Related]  

  • 10. Is there a non-dopaminergic nigrostriatal pathway?
    van der Kooy D; Coscina DV; Hattori T
    Neuroscience; 1981; 6(3):345-57. PubMed ID: 7012667
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopaminergic substrates of intracranial self-stimulation in the caudate-putamen.
    Phillips AG; Carter DA; Fibiger HC
    Brain Res; 1976 Mar; 104(2):221-32. PubMed ID: 1260420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain.
    Costall B; Naylor RJ; Olley JE
    Neuropharmacology; 1972 Sep; 11(5):645-63. PubMed ID: 4597256
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulation by dopamine of adenosine cyclic 3',5'-monophosphate formation in rat caudate nucleus: effect of lesions of the nigro-neostriatal pathway.
    Krueger BK; Forn J; Walters JR; Roth RH; Greengard P
    Mol Pharmacol; 1976 Jul; 12(4):639-48. PubMed ID: 183096
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential effects of para-chlorophenylalanine on self-stimulation in caudate-putamen and lateral hypothalamus.
    Phillips AG; Carter DA; Fibiger HC
    Psychopharmacology (Berl); 1976 Aug; 49(1):23-7. PubMed ID: 134387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features of the parkinsonian syndrome induced experimentally by a deficit of nigrostriatal dopamine and stimulation of cholinergic neurons of the caudate nuclei.
    Kryzhanovskii GN; Atadzhanov MA; Voronina TA; Nerobkova LN
    Neurosci Behav Physiol; 1994; 24(6):485-8. PubMed ID: 7715769
    [No Abstract]   [Full Text] [Related]  

  • 16. Striatal monoamines and reserpine and chlorpromazine rigidity.
    Jurna I
    Pharmacol Ther B; 1976; 2(1):113-28. PubMed ID: 178006
    [No Abstract]   [Full Text] [Related]  

  • 17. Intraventricular anti-cholinergics do not block cholinergic hippocampal RSA or neocortical desynchronization in the rabbit or rat.
    Whishaw IQ; Robinson TE; Schallert T
    Pharmacol Biochem Behav; 1976 Sep; 5(3):275-83. PubMed ID: 996060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific asymmetric behavior induced by the direct chemical stimulation of neostriatal dopaminergic mechanisms.
    Costall B; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(1):83-98. PubMed ID: 4280020
    [No Abstract]   [Full Text] [Related]  

  • 19. Functional differentiation within the neostriatum of the rat using electrical (blocking) stimulation during discrimination learning.
    Livesey PJ; Muter V
    J Comp Physiol Psychol; 1976 Feb; 90(2):203-11. PubMed ID: 1249272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of dopaminergic system of the rat neostriatum in the mechanisms of the conditioned avoidance reflex].
    Suvorov NF; Iakimovskiĭ AF
    Fiziol Zh (1978); 1982; 28(6):671-5. PubMed ID: 7173406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.